Innovotech Inc
XTSX:IOT
Innovotech Inc
Inventory
Innovotech Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Innovotech Inc
XTSX:IOT
|
Inventory
CA$149.9k
|
CAGR 3-Years
57%
|
CAGR 5-Years
28%
|
CAGR 10-Years
17%
|
|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovotech Inc
Glance View
Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States and internationally. The company is headquartered in Edmonton, Alberta. The company went IPO on 2003-05-28. The firm's contract research services cover various applications, including implanted devices antimicrobial testing; antibiotic and biocide efficacy screening; agricultural diseases, food safety; dental biofilms; waterline and pipeline fouling; regulatory submission packages; consulting services; and third-party validations. The firm's assays and services include biofilm antimicrobial testing, planktonic antimicrobial testing, aerobic and anaerobic microorganisms as well as bacterial spores. Its products include InnovoSIL Antimicrobial Products, The MBEC Assay, and Agress and AgreGuard. InnovoSIL is a family of antimicrobial agents suited to coating onto or incorporation into medical devices. The MBEC assay is biofilm growth device. Agress and AgreGuard is a seed treatment and plant spray.
See Also
What is Innovotech Inc's Inventory?
Inventory
149.9k
CAD
Based on the financial report for Sep 30, 2025, Innovotech Inc's Inventory amounts to 149.9k CAD.
What is Innovotech Inc's Inventory growth rate?
Inventory CAGR 10Y
17%
Over the last year, the Inventory growth was 59%. The average annual Inventory growth rates for Innovotech Inc have been 57% over the past three years , 28% over the past five years , and 17% over the past ten years .
